Back
Apollo Asset Management, Inc. Vs. Keros Therapeutics Industry Stock Comparison
Buy
51
APO
Apollo Asset Management, Inc.
Last Price:
$133.52
Seasonality Move:
3%
Sell
33
KROS
Keros Therapeutics
Last Price:
$14.09
Seasonality Move:
0.65%
Buy
51
Apollo Asset Management, Inc. (APO)
is a Buy
Is Apollo Asset Management, Inc. a Buy, Sell or Hold?
-
The current Apollo Asset Management, Inc. [APO] share price is $133.51. The Score for APO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
APO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $15.04. The Score for KROS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APO Stock Price Chart
What is Apollo Asset Management, Inc.'s stock price today?
-
The Apollo Asset Management, Inc. share price today is $133.51The current trend is relatively stagnant and APO is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $15.04The current trend is moderately bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
APO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.85 | Sell |
Relative Strength Index (14 RSI): | 50.1 | Buy |
Chaikin Money Flow: | -884148 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (129.29 - 140.25) | Sell |
Bollinger Bands (100): | (127.34 - 158.2) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 63.15 | Buy |
Chaikin Money Flow: | -393459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
APO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.44 | Buy |
20-day SMA: | 135.55 | Sell |
50-day SMA: | 131.64 | Buy |
200-day SMA: | 144.1 | Sell |
8-day EMA: | 132.23 | Buy |
20-day EMA: | 133.18 | Buy |
50-day EMA: | 135.21 | Sell |
200-day EMA: | 137.95 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.67 | Buy |
20-day SMA: | 14.27 | Buy |
50-day SMA: | 13.29 | Buy |
200-day SMA: | 30.84 | Sell |
8-day EMA: | 14.75 | Buy |
20-day EMA: | 14.38 | Buy |
50-day EMA: | 14.02 | Buy |
200-day EMA: | 25.44 | Sell |
Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.32 per share, an increase this year of $0.67 per share, and an increase next year of $1.61 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Apollo Asset Management, Inc. Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |